Probiotics: A role in the treatment of intestinal infection and inflammation?

Gut

Volumn 50, Issue SUPPL. 3, 2002, Pages

  Isolauri, Erika ^a   Kirjavainen, P V ^a   Salminen, S ^a  

^a UNIVERSITY OF TURKU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

PROBIOTIC AGENT; RIBOSOME RNA;

ACUTE GASTROENTERITIS; ALLERGIC DISEASE; CONFERENCE PAPER; DIET SUPPLEMENTATION; DRUG SAFETY; ENTERITIS; HUMAN; INTESTINE FLORA; INTESTINE INFECTION; LACTOBACILLUS; PRIORITY JOURNAL; RNA SEQUENCE;

EID: 0036113536     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.50.suppl_3.iii54     Document Type: Conference Paper

References (55)

1. Gastrointestinal physiology and function - Targets for functional food development
2. The indigenous gastrointestinal microflora
3. Development of intestinal microflora in humans and animals
4. Influences of microbiota on intestinal immune system development
5. The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction
6. Importance of intestinal colonisation in the maturation of humoral immunity in early infancy: A prospective follow up study of healthy infants aged 0-6 months
7. Analysis of intestinal flora development in breast-fed and formula-fed infants by using molecular identification and detection methods
8. Probiotics: Effects on immunity
9. Uptake and transport of macromolecules by the intestine: Possible role in clinical disorders (an update)
10. Mucosal tolerance
11. Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD)
12. Molecular analysis of commensal host-microbial relationships in the intestine
13. Regulatory T cells and inflammatory bowel disease
14. Fecal microflora in healthy infants born by different methods of delivery: Permanent changes in intestinal flora after cesarean delivery
15. Oral bacteriotherapy for viral gastroenteritis
16. Increased bacterial urease activity in faeces in juvenile chronic arthritis: Evidence of altered intestinal microflora?
17. Differences in the gut bacterial flora of healthy and milk-hypersensitive adults, as measured by fluorescence in situ hybridisation
18. The intestinal microflora in allergic Estonian and Swedish 2-year-old children
19. Probiotics in human disease
20. A human Lactobacillus strain (Lactobacillus GG) promotes recovery from acute diarrhea in children
21. Lactic acid bacteria in the treatment of acute rotavirus gastroenteritis
22. Lactobacillus GG and acute diarrhoea in young children in the tropics
23. Oral bacterial therapy reduces the duration of symptoms and of viral excretion in children with mild diarrhea
24. Diet during rotavirus enteritis affects jejunal permeability to macromolecules in suckling rats
25. Enhancement of the circulating antibody secreting cell response in human diarrhea by a human lactobacillus strain
26. Lactobacillus GG administered in oral rehydration solution to children with acute diarrhoea: A multicenter European trial
27. Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding of rotavirus
28. A placebo-controlled trial of Lactobacillus GG to prevent diarrhea in undernourished Peruvian children
29. Efficacy of Lactobacillus GG in prevention of nosocomial diarrhea in infants
30. Promotion of IgA immune response in patients with Crohn's disease by oral bacteriotherapy with Lactobacillus GG
31. Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice
32. Development of the mucosal immune system in humans
33. Immunological aspects of host/microbiota interactions at the intestinal epithelium
34. Hay fever, hygiene, and household size
35. Suppression of lymphocyte proliferation in vitro by bovine caseins hydrolysed with Lactobacillus GG-derived enzymes
36. Downregulation of antiCD3 antibody-induced IL-4 production by bovine caseins hydrolysed with Lactobacillus GG-derived enzymes
37. Interleukin-10 generation in atopic children following oral Lactobacillus rhamnosus GG
38. Probiotics in the management of atopic eczema
39. Probiotics: A novel approach in the management of food allergy
40. Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing
41. Probiotic bacteria downregulate the milk-induced inflammatory response in milk-hypersensitive subjects but have an immunostimulatory effect in healthy subjects
42. Probiotics in primary prevention of atopic disease: A randomised placebo-controlled trial
43. A strain of Enterococcus faecium (18C23) inhibits the adhesion of enterotoxigenic Escerichia coli K88 to porcine small intestinal mucus
44. Effects of Lactobacillus strains and oat bran on methotrexate-induced enterocolitis in rats
45. Adhesion of probiotic microorganisms to intestinal mucus
46. Qualitative approach in the study of adhesion of lactic avid bacteria on intestinal cells and their competition with enterobacteria
47. Treatment of murine colitis by Lactococcus lactis secreting interleukin-10
48. The lactic acid stress response to Lactococcus lactis subsp. lactis
49. Starvation-induced stress resistance in Lactococcus lactis subsp. lactis IL1403
50. Effect of compatible solutes on survival of lactic acid bacteria subjected to drying
51. Comparative effect of the adjuvant capacity of Lactobacillus casei and lipopolysaccharide on the intestinal secretory antibody response and resistance to salmonella infection in mice
52. Physico-chemical alterations enhance the ability of dairy strains of lactic acid bacteria to remove aflatoxin from contaminated media
53. Demonstration of safety of probiotics - A review
54. Gut origin of sepsis: A prospective study investigating associations between bacterial translocation, gastric microflora, and septic morbidity
55. Good adhesion properties of probiotics: A potential risk for bacteremia?